Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 8.81394060 |
2 | epoxygenase P450 pathway (GO:0019373) | 8.13411809 |
3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.94257098 |
4 | L-phenylalanine catabolic process (GO:0006559) | 7.75478858 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.75478858 |
6 | L-phenylalanine metabolic process (GO:0006558) | 7.40287986 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.40287986 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.93477437 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.42322681 |
10 | indole-containing compound catabolic process (GO:0042436) | 6.20859592 |
11 | indolalkylamine catabolic process (GO:0046218) | 6.20859592 |
12 | tryptophan catabolic process (GO:0006569) | 6.20859592 |
13 | kynurenine metabolic process (GO:0070189) | 6.06395461 |
14 | oxidative demethylation (GO:0070989) | 6.04642468 |
15 | drug metabolic process (GO:0017144) | 6.04029063 |
16 | bile acid biosynthetic process (GO:0006699) | 5.97548802 |
17 | tryptophan metabolic process (GO:0006568) | 5.84516159 |
18 | urea cycle (GO:0000050) | 5.83047105 |
19 | urea metabolic process (GO:0019627) | 5.83047105 |
20 | negative regulation of fibrinolysis (GO:0051918) | 5.73040303 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.70629957 |
22 | regulation of plasminogen activation (GO:0010755) | 5.65992349 |
23 | regulation of fibrinolysis (GO:0051917) | 5.51714426 |
24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51349884 |
25 | phenylpropanoid metabolic process (GO:0009698) | 5.47874358 |
26 | protein carboxylation (GO:0018214) | 5.42064075 |
27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.42064075 |
28 | nitrogen cycle metabolic process (GO:0071941) | 5.36060818 |
29 | complement activation, alternative pathway (GO:0006957) | 5.34169126 |
30 | regulation of protein activation cascade (GO:2000257) | 5.31423261 |
31 | * glyoxylate metabolic process (GO:0046487) | 5.23464797 |
32 | bile acid metabolic process (GO:0008206) | 5.11343427 |
33 | * sulfur amino acid catabolic process (GO:0000098) | 5.05093901 |
34 | aromatic amino acid family metabolic process (GO:0009072) | 5.03473622 |
35 | regulation of cholesterol esterification (GO:0010872) | 4.99215789 |
36 | reverse cholesterol transport (GO:0043691) | 4.95782366 |
37 | homocysteine metabolic process (GO:0050667) | 4.95330970 |
38 | tyrosine metabolic process (GO:0006570) | 4.94577202 |
39 | regulation of complement activation (GO:0030449) | 4.94544377 |
40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.88517079 |
41 | protein-lipid complex remodeling (GO:0034368) | 4.88517079 |
42 | macromolecular complex remodeling (GO:0034367) | 4.88517079 |
43 | ethanol metabolic process (GO:0006067) | 4.88238057 |
44 | regulation of triglyceride catabolic process (GO:0010896) | 4.87836502 |
45 | negative regulation of blood coagulation (GO:0030195) | 4.86243028 |
46 | negative regulation of hemostasis (GO:1900047) | 4.86243028 |
47 | * serine family amino acid catabolic process (GO:0009071) | 4.85116931 |
48 | * cysteine metabolic process (GO:0006534) | 4.82444773 |
49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82259644 |
50 | acute-phase response (GO:0006953) | 4.72493183 |
51 | S-adenosylmethionine metabolic process (GO:0046500) | 4.69160676 |
52 | acylglycerol homeostasis (GO:0055090) | 4.66333682 |
53 | triglyceride homeostasis (GO:0070328) | 4.66333682 |
54 | * alpha-amino acid catabolic process (GO:1901606) | 4.66111063 |
55 | alkaloid metabolic process (GO:0009820) | 4.64647634 |
56 | amino-acid betaine metabolic process (GO:0006577) | 4.64594592 |
57 | phospholipid efflux (GO:0033700) | 4.63319003 |
58 | negative regulation of cholesterol transport (GO:0032375) | 4.62613433 |
59 | negative regulation of sterol transport (GO:0032372) | 4.62613433 |
60 | regulation of humoral immune response (GO:0002920) | 4.61873028 |
61 | lysine metabolic process (GO:0006553) | 4.58788683 |
62 | lysine catabolic process (GO:0006554) | 4.58788683 |
63 | negative regulation of protein activation cascade (GO:2000258) | 4.48591571 |
64 | cellular ketone body metabolic process (GO:0046950) | 4.47897330 |
65 | plasma lipoprotein particle clearance (GO:0034381) | 4.47484526 |
66 | imidazole-containing compound metabolic process (GO:0052803) | 4.46077419 |
67 | negative regulation of coagulation (GO:0050819) | 4.42022961 |
68 | coenzyme catabolic process (GO:0009109) | 4.41151193 |
69 | bile acid and bile salt transport (GO:0015721) | 4.40921194 |
70 | indolalkylamine metabolic process (GO:0006586) | 4.40094341 |
71 | negative regulation of wound healing (GO:0061045) | 4.38017719 |
72 | cellular biogenic amine catabolic process (GO:0042402) | 4.31603200 |
73 | amine catabolic process (GO:0009310) | 4.31603200 |
74 | glutamate metabolic process (GO:0006536) | 4.30992129 |
75 | positive regulation of blood coagulation (GO:0030194) | 4.29295445 |
76 | positive regulation of hemostasis (GO:1900048) | 4.29295445 |
77 | cholesterol efflux (GO:0033344) | 4.29116286 |
78 | * cellular amino acid catabolic process (GO:0009063) | 4.28798749 |
79 | opsonization (GO:0008228) | 4.27877220 |
80 | cellular glucuronidation (GO:0052695) | 4.24209097 |
81 | benzene-containing compound metabolic process (GO:0042537) | 4.15220498 |
82 | arginine metabolic process (GO:0006525) | 4.13335251 |
83 | low-density lipoprotein particle remodeling (GO:0034374) | 4.13057031 |
84 | * glycine metabolic process (GO:0006544) | 4.12299063 |
85 | cellular modified amino acid catabolic process (GO:0042219) | 4.11952497 |
86 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.08843897 |
87 | plasma lipoprotein particle assembly (GO:0034377) | 4.07483173 |
88 | fibrinolysis (GO:0042730) | 4.07076816 |
89 | * serine family amino acid metabolic process (GO:0009069) | 4.03900094 |
90 | ethanol oxidation (GO:0006069) | 4.02712068 |
91 | positive regulation of coagulation (GO:0050820) | 3.93552601 |
92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.92539105 |
93 | drug catabolic process (GO:0042737) | 3.89399185 |
94 | ketone body metabolic process (GO:1902224) | 3.87754033 |
95 | intestinal cholesterol absorption (GO:0030299) | 3.87474966 |
96 | flavonoid metabolic process (GO:0009812) | 3.87146810 |
97 | cofactor catabolic process (GO:0051187) | 3.83436776 |
98 | negative regulation of lipase activity (GO:0060192) | 3.81978669 |
99 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80399290 |
100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.80260871 |
101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.80260871 |
102 | negative regulation of complement activation (GO:0045916) | 3.79171442 |
103 | cholesterol homeostasis (GO:0042632) | 3.76549518 |
104 | regulation of lipoprotein particle clearance (GO:0010984) | 3.76541398 |
105 | uronic acid metabolic process (GO:0006063) | 3.76185918 |
106 | glucuronate metabolic process (GO:0019585) | 3.76185918 |
107 | positive regulation of lipid catabolic process (GO:0050996) | 3.75477099 |
108 | complement activation, classical pathway (GO:0006958) | 3.75168986 |
109 | * organic acid catabolic process (GO:0016054) | 3.74472743 |
110 | * carboxylic acid catabolic process (GO:0046395) | 3.74472743 |
111 | protein activation cascade (GO:0072376) | 3.74011590 |
112 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73034933 |
113 | phospholipid homeostasis (GO:0055091) | 3.72896595 |
114 | complement activation (GO:0006956) | 3.72625690 |
115 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.70204054 |
116 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.70204054 |
117 | sterol homeostasis (GO:0055092) | 3.70139792 |
118 | plasma lipoprotein particle organization (GO:0071827) | 3.70085185 |
119 | hormone catabolic process (GO:0042447) | 3.69458406 |
120 | heme transport (GO:0015886) | 3.67603257 |
121 | acute inflammatory response (GO:0002526) | 3.66660845 |
122 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.66485235 |
123 | protein-lipid complex assembly (GO:0065005) | 3.64984988 |
124 | acetyl-CoA metabolic process (GO:0006084) | 3.64871126 |
125 | short-chain fatty acid metabolic process (GO:0046459) | 3.63591554 |
126 | regulation of cholesterol homeostasis (GO:2000188) | 3.61815820 |
127 | cytolysis (GO:0019835) | 3.60275434 |
128 | * serine family amino acid biosynthetic process (GO:0009070) | 3.60225482 |
129 | NAD biosynthetic process (GO:0009435) | 3.58964180 |
130 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.54622595 |
131 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.53622776 |
132 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.53622776 |
133 | xenobiotic metabolic process (GO:0006805) | 3.43361812 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41629716 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18791211 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.04861004 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50177961 |
5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.23177918 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.18171868 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.82105922 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03083363 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.02693028 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09591660 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0771869 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98710638 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94007651 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60442227 |
15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58045641 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52460462 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42927041 |
18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39147573 |
19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32086381 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30005639 |
21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20286949 |
22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17384855 |
23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16347045 |
24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10466309 |
25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04617962 |
26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01350829 |
27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00891585 |
28 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99746147 |
29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93803665 |
30 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.89969697 |
31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89645784 |
32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89463438 |
33 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88074378 |
34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85965755 |
35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85920982 |
36 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.85250329 |
37 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84482468 |
38 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83237694 |
39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82326857 |
40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82290473 |
41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81839492 |
42 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.81756049 |
43 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.80147986 |
44 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.79998625 |
45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79111724 |
46 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.78985881 |
47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78915257 |
48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77273564 |
49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76695748 |
50 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.76381283 |
51 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75884059 |
52 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.75227657 |
53 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75226183 |
54 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.74864208 |
55 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74422203 |
56 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.74224348 |
57 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74136307 |
58 | NFYA_21822215_ChIP-Seq_K562_Human | 0.72118453 |
59 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70702151 |
60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70603762 |
61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.70408512 |
62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69827533 |
63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.68398918 |
64 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.66096790 |
65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65686876 |
66 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.65363238 |
67 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65254913 |
68 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.65064373 |
69 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.64953275 |
70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64609752 |
71 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.64288299 |
72 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64093562 |
73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63973939 |
74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63903462 |
75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63903462 |
76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62554234 |
77 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62475946 |
78 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.62380325 |
79 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61921237 |
80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.61762459 |
81 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61069462 |
82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60368979 |
83 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.58728932 |
84 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.57812923 |
85 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.57789848 |
86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.57334717 |
87 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.57044552 |
88 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.57044552 |
89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56426877 |
90 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.56354620 |
91 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.56354620 |
92 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.55923965 |
93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55352365 |
94 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.54403459 |
95 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.54332373 |
96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53971292 |
97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.53360684 |
98 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.53171983 |
99 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52529699 |
100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52503427 |
101 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.52091987 |
102 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52076390 |
103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.51961097 |
104 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51787584 |
105 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.51351039 |
106 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.51078821 |
107 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50999150 |
108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.50978328 |
109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50240175 |
110 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50102778 |
111 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49205252 |
112 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48323623 |
113 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47498712 |
114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47011606 |
115 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46461703 |
116 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.45943655 |
117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43632273 |
118 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43412503 |
119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43273693 |
120 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42558247 |
121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42450007 |
122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42375250 |
123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41725243 |
124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41416543 |
125 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.41223407 |
126 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40810909 |
127 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40549934 |
128 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40056731 |
129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39817341 |
130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39602598 |
131 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38844535 |
132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38801893 |
133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37464595 |
134 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37230793 |
135 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37230588 |
136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37078304 |
137 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.36947335 |
138 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36771681 |
139 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35394813 |
140 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33879236 |
141 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33855267 |
142 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33788330 |
143 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33181610 |
144 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.32795510 |
145 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.32794720 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.45545248 |
2 | * MP0005360_urolithiasis | 6.87812408 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.60166019 |
4 | MP0005365_abnormal_bile_salt | 6.31338201 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.25530058 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.35106196 |
7 | MP0003252_abnormal_bile_duct | 3.99157844 |
8 | MP0010329_abnormal_lipoprotein_level | 3.68706164 |
9 | MP0009840_abnormal_foam_cell | 3.40426312 |
10 | MP0005083_abnormal_biliary_tract | 3.11823324 |
11 | MP0005332_abnormal_amino_acid | 2.85882213 |
12 | MP0001666_abnormal_nutrient_absorption | 2.63683714 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.41620911 |
14 | MP0000609_abnormal_liver_physiology | 2.21334584 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.17583949 |
16 | MP0002118_abnormal_lipid_homeostasis | 2.14760522 |
17 | MP0002138_abnormal_hepatobiliary_system | 2.03181114 |
18 | MP0003868_abnormal_feces_composition | 1.95914691 |
19 | MP0005319_abnormal_enzyme/_coenzyme | 1.87207869 |
20 | MP0001764_abnormal_homeostasis | 1.74892142 |
21 | MP0009697_abnormal_copulation | 1.65046472 |
22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61610091 |
23 | MP0005451_abnormal_body_composition | 1.53600681 |
24 | * MP0003195_calcinosis | 1.48124531 |
25 | MP0003011_delayed_dark_adaptation | 1.43243433 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 1.32807234 |
27 | MP0003186_abnormal_redox_activity | 1.31597810 |
28 | MP0000598_abnormal_liver_morphology | 1.21433503 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.21427423 |
30 | * MP0009643_abnormal_urine_homeostasis | 1.20174681 |
31 | MP0005647_abnormal_sex_gland | 1.14475374 |
32 | MP0000604_amyloidosis | 1.13409452 |
33 | MP0009764_decreased_sensitivity_to | 1.08056648 |
34 | MP0009763_increased_sensitivity_to | 1.04981065 |
35 | MP0002254_reproductive_system_inflammat | 1.03613012 |
36 | MP0010368_abnormal_lymphatic_system | 1.00218143 |
37 | MP0005636_abnormal_mineral_homeostasis | 0.94356720 |
38 | MP0005187_abnormal_penis_morphology | 0.91968072 |
39 | MP0008469_abnormal_protein_level | 0.91317245 |
40 | MP0009642_abnormal_blood_homeostasis | 0.89838476 |
41 | MP0005408_hypopigmentation | 0.87736013 |
42 | MP0002282_abnormal_trachea_morphology | 0.84026123 |
43 | MP0006036_abnormal_mitochondrial_physio | 0.83495885 |
44 | MP0005376_homeostasis/metabolism_phenot | 0.83431627 |
45 | MP0001915_intracranial_hemorrhage | 0.81936650 |
46 | MP0005670_abnormal_white_adipose | 0.80346250 |
47 | MP0009765_abnormal_xenobiotic_induced | 0.80288906 |
48 | MP0002078_abnormal_glucose_homeostasis | 0.79525809 |
49 | MP0003879_abnormal_hair_cell | 0.76888137 |
50 | MP0002876_abnormal_thyroid_physiology | 0.76573245 |
51 | MP0005084_abnormal_gallbladder_morpholo | 0.75977933 |
52 | MP0002971_abnormal_brown_adipose | 0.73536506 |
53 | MP0005220_abnormal_exocrine_pancreas | 0.72865345 |
54 | MP0003690_abnormal_glial_cell | 0.69762458 |
55 | MP0004130_abnormal_muscle_cell | 0.69713397 |
56 | MP0001661_extended_life_span | 0.69520560 |
57 | MP0005334_abnormal_fat_pad | 0.69445892 |
58 | MP0005535_abnormal_body_temperature | 0.68629492 |
59 | MP0009053_abnormal_anal_canal | 0.68329084 |
60 | MP0005266_abnormal_metabolism | 0.66834256 |
61 | MP0000639_abnormal_adrenal_gland | 0.64571396 |
62 | MP0003329_amyloid_beta_deposits | 0.64436085 |
63 | MP0002249_abnormal_larynx_morphology | 0.63593472 |
64 | MP0001756_abnormal_urination | 0.60169793 |
65 | MP0000566_synostosis | 0.57439932 |
66 | MP0005448_abnormal_energy_balance | 0.57318873 |
67 | MP0006035_abnormal_mitochondrial_morpho | 0.57059109 |
68 | MP0005464_abnormal_platelet_physiology | 0.56755022 |
69 | MP0002822_catalepsy | 0.52256090 |
70 | MP0009785_altered_susceptibility_to | 0.51904791 |
71 | MP0003638_abnormal_response/metabolism_ | 0.48279537 |
72 | MP0008874_decreased_physiological_sensi | 0.48212910 |
73 | MP0003718_maternal_effect | 0.47271889 |
74 | MP0008873_increased_physiological_sensi | 0.46815169 |
75 | MP0003436_decreased_susceptibility_to | 0.45222568 |
76 | MP0002928_abnormal_bile_duct | 0.44805193 |
77 | MP0002837_dystrophic_cardiac_calcinosis | 0.44667182 |
78 | MP0003724_increased_susceptibility_to | 0.44078238 |
79 | MP0004782_abnormal_surfactant_physiolog | 0.43913280 |
80 | MP0003075_altered_response_to | 0.42999461 |
81 | MP0001986_abnormal_taste_sensitivity | 0.42597995 |
82 | MP0003953_abnormal_hormone_level | 0.41632706 |
83 | MP0005248_abnormal_Harderian_gland | 0.41360131 |
84 | * MP0002136_abnormal_kidney_physiology | 0.40990286 |
85 | MP0008872_abnormal_physiological_respon | 0.39727476 |
86 | MP0004381_abnormal_hair_follicle | 0.39056637 |
87 | MP0005166_decreased_susceptibility_to | 0.38828804 |
88 | MP0009672_abnormal_birth_weight | 0.38335635 |
89 | MP0005666_abnormal_adipose_tissue | 0.36708666 |
90 | * MP0005395_other_phenotype | 0.36063851 |
91 | MP0004883_abnormal_blood_vessel | 0.35511512 |
92 | MP0000249_abnormal_blood_vessel | 0.35209761 |
93 | MP0000579_abnormal_nail_morphology | 0.34413412 |
94 | MP0000230_abnormal_systemic_arterial | 0.33750085 |
95 | MP0001243_abnormal_dermal_layer | 0.33280920 |
96 | MP0009115_abnormal_fat_cell | 0.32916797 |
97 | MP0006082_CNS_inflammation | 0.32848374 |
98 | MP0002796_impaired_skin_barrier | 0.32438807 |
99 | MP0009384_cardiac_valve_regurgitation | 0.31572860 |
100 | MP0002970_abnormal_white_adipose | 0.30723267 |
101 | MP0010386_abnormal_urinary_bladder | 0.29731302 |
102 | MP0001853_heart_inflammation | 0.29679495 |
103 | MP0005646_abnormal_pituitary_gland | 0.29663177 |
104 | MP0001845_abnormal_inflammatory_respons | 0.29353849 |
105 | MP0005023_abnormal_wound_healing | 0.29104188 |
106 | MP0001881_abnormal_mammary_gland | 0.27926283 |
107 | MP0006292_abnormal_olfactory_placode | 0.27652209 |
108 | MP0005164_abnormal_response_to | 0.27429859 |
109 | MP0005551_abnormal_eye_electrophysiolog | 0.26439418 |
110 | MP0000467_abnormal_esophagus_morphology | 0.25970381 |
111 | MP0002132_abnormal_respiratory_system | 0.25187119 |
112 | MP0002089_abnormal_postnatal_growth/wei | 0.25102086 |
113 | MP0001944_abnormal_pancreas_morphology | 0.24638525 |
114 | MP0002090_abnormal_vision | 0.24526699 |
115 | MP0005167_abnormal_blood-brain_barrier | 0.23896479 |
116 | MP0005058_abnormal_lysosome_morphology | 0.23694179 |
117 | MP0003959_abnormal_lean_body | 0.23539577 |
118 | MP0002909_abnormal_adrenal_gland | 0.23441719 |
119 | MP0004142_abnormal_muscle_tone | 0.23279100 |
120 | MP0005377_hearing/vestibular/ear_phenot | 0.21195623 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.56769486 |
2 | Deep venous thrombosis (HP:0002625) | 7.49291769 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.35806843 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.79309109 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.63678697 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.49870657 |
7 | Xanthomatosis (HP:0000991) | 6.32671228 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.69563632 |
9 | Complement deficiency (HP:0004431) | 5.30641659 |
10 | Joint hemorrhage (HP:0005261) | 4.88021776 |
11 | Hypolipoproteinemia (HP:0010981) | 4.87592043 |
12 | Hyperammonemia (HP:0001987) | 4.65687026 |
13 | Epidermoid cyst (HP:0200040) | 4.55201675 |
14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.50323573 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.46052882 |
16 | Abnormality of methionine metabolism (HP:0010901) | 4.43585178 |
17 | Hyperglycinemia (HP:0002154) | 4.40003426 |
18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.36644010 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 4.28207633 |
20 | Ketosis (HP:0001946) | 4.25316856 |
21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22399745 |
22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.20261463 |
23 | Fat malabsorption (HP:0002630) | 4.10948220 |
24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.93628442 |
25 | Hyperglycinuria (HP:0003108) | 3.90836549 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88783650 |
27 | Abnormality of glycine metabolism (HP:0010895) | 3.88783650 |
28 | Abnormality of complement system (HP:0005339) | 3.87351043 |
29 | Hypoglycemic coma (HP:0001325) | 3.79781224 |
30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78441764 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70538637 |
32 | Hypercholesterolemia (HP:0003124) | 3.65404803 |
33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36324185 |
34 | Hyperbilirubinemia (HP:0002904) | 3.35953728 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32470140 |
36 | Delayed CNS myelination (HP:0002188) | 3.11696474 |
37 | Abnormality of serum amino acid levels (HP:0003112) | 3.09230254 |
38 | Spontaneous abortion (HP:0005268) | 3.08722454 |
39 | Steatorrhea (HP:0002570) | 3.08295069 |
40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07587244 |
41 | Hepatocellular carcinoma (HP:0001402) | 3.02168317 |
42 | Hypochromic microcytic anemia (HP:0004840) | 2.98348437 |
43 | Ketoacidosis (HP:0001993) | 2.96176854 |
44 | Myocardial infarction (HP:0001658) | 2.95849229 |
45 | Skin nodule (HP:0200036) | 2.81754021 |
46 | Systemic lupus erythematosus (HP:0002725) | 2.69921781 |
47 | Abnormality of purine metabolism (HP:0004352) | 2.64566645 |
48 | Lethargy (HP:0001254) | 2.62617043 |
49 | Reduced antithrombin III activity (HP:0001976) | 2.62033717 |
50 | * Metabolic acidosis (HP:0001942) | 2.60604925 |
51 | Vascular calcification (HP:0004934) | 2.60283712 |
52 | Acanthocytosis (HP:0001927) | 2.58572549 |
53 | Purpura (HP:0000979) | 2.58297041 |
54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56966758 |
55 | Dicarboxylic aciduria (HP:0003215) | 2.56966758 |
56 | Fair hair (HP:0002286) | 2.56195712 |
57 | Osteomalacia (HP:0002749) | 2.52666811 |
58 | Spastic diplegia (HP:0001264) | 2.48348695 |
59 | Glomerulonephritis (HP:0000099) | 2.48164905 |
60 | Cerebral edema (HP:0002181) | 2.48110282 |
61 | Abnormal gallbladder morphology (HP:0012437) | 2.46987549 |
62 | Mitral stenosis (HP:0001718) | 2.45437964 |
63 | Gout (HP:0001997) | 2.42757212 |
64 | Cholelithiasis (HP:0001081) | 2.39981138 |
65 | Hypoglycemic seizures (HP:0002173) | 2.39841777 |
66 | Neonatal onset (HP:0003623) | 2.38947898 |
67 | Irritability (HP:0000737) | 2.38024819 |
68 | Amyloidosis (HP:0011034) | 2.37475982 |
69 | Cardiovascular calcification (HP:0011915) | 2.30948514 |
70 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30024677 |
71 | Gingival bleeding (HP:0000225) | 2.26300937 |
72 | Abnormal gallbladder physiology (HP:0012438) | 2.24990050 |
73 | Cholecystitis (HP:0001082) | 2.24990050 |
74 | Malnutrition (HP:0004395) | 2.22767682 |
75 | Esophageal varix (HP:0002040) | 2.19890498 |
76 | Menorrhagia (HP:0000132) | 2.19625961 |
77 | Arthropathy (HP:0003040) | 2.18781590 |
78 | Neonatal hypoglycemia (HP:0001998) | 2.17053169 |
79 | Pancreatitis (HP:0001733) | 2.14500447 |
80 | Thrombophlebitis (HP:0004418) | 2.12575105 |
81 | Enlarged kidneys (HP:0000105) | 2.11642589 |
82 | Sensorimotor neuropathy (HP:0007141) | 2.11541166 |
83 | Brushfield spots (HP:0001088) | 2.11056373 |
84 | Hyperphosphaturia (HP:0003109) | 2.08212675 |
85 | Vomiting (HP:0002013) | 2.07305796 |
86 | Late onset (HP:0003584) | 2.05267371 |
87 | Poikilocytosis (HP:0004447) | 2.04018811 |
88 | Opisthotonus (HP:0002179) | 2.01349606 |
89 | Generalized aminoaciduria (HP:0002909) | 2.01012838 |
90 | Glycosuria (HP:0003076) | 2.00958998 |
91 | Abnormality of urine glucose concentration (HP:0011016) | 2.00958998 |
92 | Abnormality of the gallbladder (HP:0005264) | 1.99899572 |
93 | Hemorrhage of the eye (HP:0011885) | 1.99891176 |
94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93731130 |
95 | Abnormality of iron homeostasis (HP:0011031) | 1.93199837 |
96 | Rickets (HP:0002748) | 1.91419088 |
97 | Bile duct proliferation (HP:0001408) | 1.90340457 |
98 | Abnormal biliary tract physiology (HP:0012439) | 1.90340457 |
99 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88778432 |
100 | Abnormal cartilage morphology (HP:0002763) | 1.87388677 |
101 | Hypophosphatemic rickets (HP:0004912) | 1.86512067 |
102 | Alkalosis (HP:0001948) | 1.86460930 |
103 | Increased serum ferritin (HP:0003281) | 1.86148555 |
104 | Elevated alkaline phosphatase (HP:0003155) | 1.84565053 |
105 | Abnormality of the Achilles tendon (HP:0005109) | 1.83335098 |
106 | Hydroxyprolinuria (HP:0003080) | 1.83218546 |
107 | Abnormality of proline metabolism (HP:0010907) | 1.83218546 |
108 | Renal cortical cysts (HP:0000803) | 1.83086290 |
109 | Elevated hepatic transaminases (HP:0002910) | 1.81701797 |
110 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79852512 |
111 | Bifid scrotum (HP:0000048) | 1.78830552 |
112 | Status epilepticus (HP:0002133) | 1.78586181 |
113 | Generalized hypopigmentation of hair (HP:0011358) | 1.77420412 |
114 | Nephritis (HP:0000123) | 1.75785684 |
115 | Abnormality of vitamin metabolism (HP:0100508) | 1.72217584 |
116 | Pulmonary embolism (HP:0002204) | 1.71998309 |
117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70678740 |
118 | Cerebral palsy (HP:0100021) | 1.67803928 |
119 | Joint swelling (HP:0001386) | 1.66007903 |
120 | Abnormal urine phosphate concentration (HP:0012599) | 1.64353439 |
121 | Epistaxis (HP:0000421) | 1.59897481 |
122 | Increased serum pyruvate (HP:0003542) | 1.54183518 |
123 | Blue irides (HP:0000635) | 1.51452698 |
124 | Increased mean platelet volume (HP:0011877) | 1.50457792 |
125 | Retinal atrophy (HP:0001105) | 1.48917846 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.30155130 |
2 | FGFR4 | 4.69528355 |
3 | SIK1 | 4.56512019 |
4 | ERN1 | 4.30532413 |
5 | TAOK3 | 3.02466455 |
6 | INSRR | 2.95812126 |
7 | ERBB4 | 2.87664453 |
8 | PIK3CA | 2.50976428 |
9 | MAP2K4 | 2.35973809 |
10 | PKN2 | 2.27601630 |
11 | NTRK3 | 2.12472409 |
12 | MST1R | 2.08670979 |
13 | FLT3 | 1.93972213 |
14 | MAPK11 | 1.88715853 |
15 | PIK3CG | 1.81414305 |
16 | TRIB3 | 1.80922530 |
17 | WNK3 | 1.79255032 |
18 | TYK2 | 1.73782647 |
19 | LATS1 | 1.60954364 |
20 | DAPK2 | 1.58813602 |
21 | ABL2 | 1.49704957 |
22 | PTK6 | 1.49529411 |
23 | WNK4 | 1.48934347 |
24 | FGFR2 | 1.40029660 |
25 | CAMKK2 | 1.39812545 |
26 | NEK9 | 1.34313084 |
27 | KDR | 1.32869849 |
28 | FRK | 1.32100332 |
29 | JAK2 | 1.23021300 |
30 | MAP3K7 | 1.18741723 |
31 | PINK1 | 1.16049865 |
32 | TNK2 | 1.14354015 |
33 | MAP4K2 | 1.13888947 |
34 | PRKACA | 1.12415386 |
35 | PRKG1 | 1.12052823 |
36 | ADRBK2 | 1.09498150 |
37 | PRKAA2 | 1.09081322 |
38 | GRK6 | 1.08548048 |
39 | TBK1 | 1.07223804 |
40 | MAP2K3 | 1.04692215 |
41 | ERBB2 | 1.03788810 |
42 | MAP3K10 | 1.02594124 |
43 | JAK1 | 1.02120735 |
44 | MAPK4 | 0.99418897 |
45 | CSNK1D | 0.95030256 |
46 | MAP3K14 | 0.94285130 |
47 | ACVR1B | 0.93203063 |
48 | PRKCZ | 0.92865789 |
49 | EPHB1 | 0.88661097 |
50 | MAPK15 | 0.87594423 |
51 | NLK | 0.86906193 |
52 | MET | 0.84796979 |
53 | PDK2 | 0.82654864 |
54 | MAPK12 | 0.82549235 |
55 | STK38L | 0.81290283 |
56 | CDK6 | 0.80912859 |
57 | TIE1 | 0.79453777 |
58 | MAP3K3 | 0.79422145 |
59 | EPHA3 | 0.78190083 |
60 | MAP3K11 | 0.78059615 |
61 | MUSK | 0.77937238 |
62 | PRKACG | 0.76545711 |
63 | MAPKAPK3 | 0.76078786 |
64 | AKT3 | 0.75314208 |
65 | FER | 0.73786021 |
66 | CAMK2G | 0.72257123 |
67 | CSK | 0.70408246 |
68 | DYRK1B | 0.70024624 |
69 | SGK1 | 0.68722568 |
70 | STK16 | 0.68692030 |
71 | MAP2K6 | 0.67685743 |
72 | BMPR1B | 0.66270186 |
73 | GSK3A | 0.66228253 |
74 | PRKCB | 0.64765081 |
75 | PRKAA1 | 0.64112923 |
76 | CAMKK1 | 0.63687523 |
77 | CASK | 0.62582789 |
78 | SGK3 | 0.61998340 |
79 | RPS6KA3 | 0.60496533 |
80 | DYRK2 | 0.60297042 |
81 | MAPK7 | 0.60001580 |
82 | CAMK1D | 0.59587765 |
83 | CSF1R | 0.59558953 |
84 | MAP3K12 | 0.59214173 |
85 | RIPK1 | 0.58121730 |
86 | FGFR3 | 0.57753787 |
87 | PRKACB | 0.57527923 |
88 | TGFBR2 | 0.57511023 |
89 | IRAK3 | 0.57398978 |
90 | CSNK2A1 | 0.57224733 |
91 | PTK2 | 0.57206002 |
92 | IKBKE | 0.55290443 |
93 | CSNK1E | 0.54080819 |
94 | CSNK1G1 | 0.53065744 |
95 | PRKCQ | 0.53057717 |
96 | PDPK1 | 0.52577177 |
97 | CSNK1A1 | 0.52159470 |
98 | PRKCE | 0.51140502 |
99 | EPHA4 | 0.50782692 |
100 | MYLK | 0.49997451 |
101 | MAP3K2 | 0.48132940 |
102 | CSNK2A2 | 0.48046280 |
103 | BCR | 0.47093267 |
104 | GRK1 | 0.46299995 |
105 | SGK2 | 0.44911076 |
106 | TAOK2 | 0.44515033 |
107 | IGF1R | 0.43646762 |
108 | PRKCG | 0.42966503 |
109 | RET | 0.41709787 |
110 | MAP2K1 | 0.41660161 |
111 | MAP3K5 | 0.41407562 |
112 | CDK4 | 0.41102619 |
113 | MAP3K13 | 0.40992699 |
114 | PBK | 0.39080619 |
115 | TLK1 | 0.38773278 |
116 | PKN1 | 0.38622214 |
117 | ICK | 0.38446707 |
118 | CHUK | 0.36941739 |
119 | SRC | 0.36834484 |
120 | MTOR | 0.34429070 |
121 | CSNK1G2 | 0.34230048 |
122 | DYRK1A | 0.33811414 |
123 | EGFR | 0.33278587 |
124 | MAP3K6 | 0.33224767 |
125 | CSNK1G3 | 0.32823398 |
126 | PDK1 | 0.32351074 |
127 | CAMK4 | 0.32092666 |
128 | SGK223 | 0.31700729 |
129 | SGK494 | 0.31700729 |
130 | BRSK2 | 0.30909596 |
131 | MAP3K1 | 0.26508034 |
132 | PRKCA | 0.25945175 |
133 | LATS2 | 0.25112893 |
134 | IRAK2 | 0.24329704 |
135 | IRAK1 | 0.24110990 |
136 | CSNK1A1L | 0.23215319 |
137 | MAP2K2 | 0.20937254 |
138 | ABL1 | 0.20462838 |
139 | PAK3 | 0.20389183 |
140 | BMX | 0.19280414 |
141 | MAPK3 | 0.18089494 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54780505 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.71325486 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.49707681 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35453025 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.16170558 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79916197 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68829237 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66231899 |
9 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.47267262 |
10 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46845813 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46813513 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37403417 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24107677 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13421930 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13272145 |
16 | * Peroxisome_Homo sapiens_hsa04146 | 2.01054674 |
17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96511265 |
18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93860357 |
19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93512441 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92087279 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91071034 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85806779 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78433517 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77968553 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77855618 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76661668 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70469293 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69443771 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65953231 |
30 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63344135 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62698580 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60985440 |
33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60812245 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54851951 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52814829 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.49087098 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46799616 |
38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.38409748 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37022849 |
40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33430760 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32456966 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26073301 |
43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23226513 |
44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22898222 |
45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22233740 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.19314782 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16136640 |
48 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.06230504 |
49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04885544 |
50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97786378 |
51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97709931 |
52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97653351 |
53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96673463 |
54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95491337 |
55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90889291 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87211921 |
57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85836340 |
58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85731009 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80123459 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77423684 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68409787 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64928868 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63733141 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57625600 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50680285 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46347459 |
67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45823732 |
68 | Prion diseases_Homo sapiens_hsa05020 | 0.35164050 |
69 | Pertussis_Homo sapiens_hsa05133 | 0.33949469 |
70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32935326 |
71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24560695 |
72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23722054 |
73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22820530 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.22595602 |
75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22196187 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21777618 |
77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19493793 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15605376 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09229938 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01618020 |
81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.01236972 |
82 | Mineral absorption_Homo sapiens_hsa04978 | 0.00651714 |
83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.00276115 |
84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2443870 |
85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2421581 |
86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2416276 |
87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2351547 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2286921 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2266736 |
90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2123344 |
91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2027074 |
92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1930071 |
93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1882760 |
94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1862844 |
95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1837126 |
96 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1711390 |
97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1669192 |
98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1638120 |
99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1598911 |
100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1576527 |
101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1552351 |
102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1468160 |
103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1380818 |
104 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1347840 |
105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1076372 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0893112 |
107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0870025 |
108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0648191 |
109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0393402 |